Erchonia, a US based provider of low level laser healthcare applications, will supply its FDA-approved body-contouring laser, Zerona in the European countries.
The company is now set to distribute its products through Erchonia Europe across 28 European countries.
Zerona device, which guarantees three inches lost in as little as two weeks, showed efficacy in a double-blind, multi-site, placebo-controlled study.
Erchonia vice president Charlie Shanks said they are looking forward to launching other Erchonia products in the European market.